ARBOR LIFE LABS

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Arbor Life Labs develops therapeutics based on stem cell activation via regulation of the Wnt/𝛽-Catenin pathway. Our patent pending platform regulates the Wnt/Beta-Catenin pathway complemented by modulating multiple disease and tissue specific molecular targets. We develop therapeutics to address a range of Aging related Degenerative Conditions to increase Healthspan and Lifespan.We seek partners for product commercialization and development and in the areas of dermatology, regenerative medicine and immunoregulation.
Company Type:
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
ALRV5XR
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
10
Speaker
photo
CEO
ARBOR LIFE LABS